Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
FDA approves Teva's digital COPD, asthma inhaler - Drug Delivery Business
Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire
Teva Pharmaceuticals on Twitter: "#DYK: #Asthma costs the United States $56 billion each year. #ACAAI16… "
Teva's severe eosinophilic asthma drug Cinqaero wins EU approval
Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment | Medgadget
Teva Pharmaceuticals on Twitter: "Identifying and avoiding #asthma triggers is an important part of asthma management. Explore the full infographic to learn more:https://t.co/mcMPquGCK7 #AsthmaAwarenssMonth #TevaUSA https://t.co/oyHHSElokt" / Twitter
Teva Announces FDA approval of AirDuo® Digihaler™
Teva Pharmaceuticals buys smart inhaler company Gecko Health Innovations | MobiHealthNews
Teva Pharmaceuticals USA - Home | Facebook
Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol | Business Wire
Teva Pharmaceuticals on Twitter: "Are you attending #AAAAI21? Be sure to visit our virtual booth to learn more about Teva's work to improve care for #asthma and #COPD patients. https://t.co/2vgkja3Zli https://t.co/ybwPHkAdOX" /
Teva Pharmaceuticals USA - While doing everything we can to decrease the risk of #COVID19 infection, it's especially important for those who live with a respiratory condition like #asthma to have a
Teva wins FDA nod for inhaled asthma medications - Drug Delivery Business
Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena
Teva's digital inhaler cleared by FDA | MobiHealthNews
Teva Develops First FDA-Approved Digitally-Integrated Inhaler
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
Teva launches digital asthma and COPD rescue inhaler in US -
FDA Approves Two Breath-actuated Asthma Meds from Teva | RT
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva's injectable asthma biologic approved by FDA - The Pharmaceutical Journal
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
Teva Pharmaceuticals - Wikipedia
Subcutaneous Cinqair results add to Teva's troubles
